Minneapolis Clinical Trials
Affinity Study
Purpose: to evaluate the safety and tolerability of an investigational medication in combination with a FDA approved medication for the treatment of weight gain as a drug side effect.
16 nights
2 visits
Participate in a clinical study of a potential treatment for weight gain while taking psychiatric medication.
This study has 1 screening appointment, 1 inpatient stay of 16 nights/ 17 days and 1 outpatient visit and 1 follow up phone call.
Reimbursement for study participation will be provided for time and travel of up to $9,090.
This study involves an FDA approved medication and an investigational study drug.
This study has been reviewed by an independent ethics committee.
Call 612-315-6490 to discuss your eligibility today!
Eligibility
Age: 18-50
BMI: 18-27.5 kg/m2
Medication: After the screening visit, please do not take any new prescription or over-the-counter medications, herbal remedies, or nutritional supplements such as multivitamins from your screening visit and until after your final visit without the approval of the study investigator. You are allowed to take acetaminophen (Tylenol) after the screening visit.
Contraception: Willing to adhere to the contraception requirements for this study
Smoking Status: Smokers are allowed, however, not allowed to smoke while inpatient.
Dose Administration: Must be able to consume a High-fat meal on Days 1, 8, and 15 within 15 minutes.